RET, ret proto-oncogene, 5979

N. diseases: 607; N. variants: 162
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Multiple Endocrine Neoplasia Type 2b
1.000 Biomarker disease GENOMICS_ENGLAND
Multiple Endocrine Neoplasia Type 2b
1.000 Biomarker disease CTD_human
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE The gene(s) responsible for two additional dominantly inherited disorders involving cancer of the medullary thyroid, MEN 2B (MEN2B), and dominantly inherited MTC without additional clinical features (MTC1), also map to this region. 1351867 1992
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease UNIPROT A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. 7906866 1994
Multiple Endocrine Neoplasia Type 2b
1.000 CausalMutation disease CLINVAR Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. 7915165 1994
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease UNIPROT Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. 7911697 1994
Multiple Endocrine Neoplasia Type 2b
1.000 CausalMutation disease CLINVAR A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. 7906866 1994
Multiple Endocrine Neoplasia Type 2b
1.000 CausalMutation disease CLINVAR Sequence analysis of germ-line DNA from MEN 2B patients revealed the existence of the same point mutation in the RET protooncogene in 34 unrelated individuals. 7906417 1994
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. 7906417 1994
Multiple Endocrine Neoplasia Type 2b
1.000 CausalMutation disease CLINVAR RET proto-oncogene mutations in French MEN 2A and FMTC families. 7874109 1994
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease UNIPROT Sequence analysis of germ-line DNA from MEN 2B patients revealed the existence of the same point mutation in the RET protooncogene in 34 unrelated individuals. 7906417 1994
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. 7906866 1994
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE Since germline mutations in the RET proto-oncogene (RET) predisposing to tumor development in Familial Medullary Thyroid Carcinoma (FMTC), Multiple endocrine neoplasia type 2A (MEN 2A), and Multiple endocrine neoplasia type 2B (MEN 2B) were reported, it has become possible to identify gene carriers with a very high degree of accuracy. 7987299 1994
Multiple Endocrine Neoplasia Type 2b
1.000 CausalMutation disease CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936 1995
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE This family demonstrates some of the phenotypic features of the multiple endocrine neoplasia type 2B syndrome without the characteristic neoplasms or the mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B. 7573303 1995
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease CLINVAR RET activation by germline MEN2A and MEN2B mutations. 8570194 1995
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE No mutation at codon 918 of the RET gene in a family with multiple endocrine neoplasia type 2B. 8736281 1995
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE Germ line mutation in the RET proto-oncogene associated with familial multiple endocrine neoplasia type 2B: a case report. 7596047 1995
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE Germline mutations in the RET protooncogene are associated with multiple endocrine neoplasia (MEN) type 2A, familial medullary thyroid carcinoma (FMTC), and MEN type 2B. 8625130 1995
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE On the other hand, one codon of RET exon 16 is preferentially changed in MEN 2B patients. 7784092 1995
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease UNIPROT Two maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B. 8595427 1995
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE These changes in autophosphorylation suggest that the MEN2B mutation may result in the more aggressive MEN2B phenotype by altering the receptor's signaling capabilities. 8621380 1996
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2B (MEN 2B) is caused by the mutation of a conserved methionine to a threonine in the catalytic domain of the RET kinase. 8621456 1996
Multiple Endocrine Neoplasia Type 2b
1.000 CausalMutation disease CLINVAR Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds. 8909322 1996
Multiple Endocrine Neoplasia Type 2b
1.000 GeneticVariation disease BEFREE To investigate whether these inherited mutations alone can cause the development of tumors in vivo (oncogene model) or whether somatic mutations in the homologous RET allele are required for tumorigenesis (tumor suppressor gene model), we analyzed the entire coding region of both alleles of the RET gene in two MEN 2A and two MEN 2B tumors by reverse transcription-PCR and direct sequencing. 8895732 1996